Definitive Contract 75D30120C08737

Award Date 9/10/20
Potential Completion Date 12/31/21
Potential Value $3.5M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Baltimore, MD 21218, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Johns Hopkins University has been awarded a $1,325,387 firm fixed price delivery order against the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) indefinite-delivery/indefinite-quantity multiple award contract by the Department of Health and Human Services Centers for Disease Control and Prevention located in Pittsburgh, Pennsylvania. The objective of this contract is to conduct a SARS-COV2 Adult Inpatient/Outpatient Vaccine Evaluation Case Control...
This is a cost-no-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Johns Hopkins University, a private research university, to provide COVID-19 response efforts. The $1,835,654.79 contract has a performance period running from July 1, 2020 through June 30, 2023. As part of this contract, Vanderbilt University Medical Center (VUMC) is serving as a subcontractor to provide molecular testing and epidemiology support, including day-to-day supervision...
This is a $496,882 firm-fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Johns Hopkins University (JHU) for research and development (R&D) services. The contract has an ultimate completion date of August 29, 2026. JHU is a private, nonprofit research university located in Baltimore, Maryland that frequently supports the CDC and other federal agencies through prime and subcontract work in areas like biomedical research, public health...
This is a $611,000 definitive cost-no-fee contract awarded to The Johns Hopkins University, a private non-profit research university, by an unspecified U.S. government agency. The contract, which does not have a set-aside designation, was awarded on September 30, 1996 with a completion date of September 30, 1999. Based on The Johns Hopkins University's background in biomedical research, public health initiatives, and scientific analysis for federal agencies like the National Institutes of Health...
The Centers for Disease Control and Prevention awarded a $378,242 firm fixed price contract to The Johns Hopkins University School of Public Health. Per the pre-solicitation notice, this contract funds a feasibility study of the Composite of Post Event Well-Being production environment pioneered by Johns Hopkins since 2012. Johns Hopkins will conduct the study and disseminate findings in peer-reviewed journals, leveraging their expertise and intellectual property related to the COPEWELL model....
This is a $1,179,816.58 firm fixed-price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to The Johns Hopkins University, a private research university located in Baltimore, Maryland. The delivery order is part of the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) indefinite delivery, indefinite quantity (IDIQ) contract, which allows the CDC to procure public health and epidemiology research and related services. This...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Definitive Contract to The Johns Hopkins University, a private non-profit university and research institution, to conduct BARRIERS RESEARCH. The $487,334.00 contract, which does not have a set-aside designation, was awarded on December 1, 2017 with a completion date of November 30, 2018. The contract supports the CDC's mission to advance public health through national immunization...
This is a $484,278 federal contract awarded by the Centers for Disease Control and Prevention (CDC) to The Johns Hopkins University (JHU) to conduct an "Evaluation of Maternal Vaccination." The contract was awarded on September 12, 2016 and has a completion date of September 30, 2019. It is a definitive, firm fixed-price contract and was not set aside for any specific business type. The award provides funding for JHU to perform clinical immunization safety assessments and research to...
This is a $523,560.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Johns Hopkins University, a private research university located in Baltimore, Maryland. The contract is for a FY 22 Broad Agency Announcement (BAA) Topic 2 requirement to provide public health communication services to increase trust. The contract has a period of performance through September 11, 2024 and does not have a set-aside designation. The Johns Hopkins...
<p>The Centers for Disease Control and Prevention (CDC) awarded a $914,074.43 definitive contract to The Johns Hopkins University under Broad Agency Announcement Topic 22.1 to assess the molecular epidemiology of Group A Streptococcus isolates among children. The prime contractor, The Johns Hopkins University, will perform this work in Baltimore, Maryland over a two-year period from September 2022 through September 2024. The contract utilizes a firm fixed price contract type.</p>

The Johns Hopkins University (JHU) was awarded a definitive cost-no-fee contract valued at $3.51 million by the Centers for Disease Control and Prevention (CDC) to conduct the JHU COVID-19 Pediatric Study. The study will be performed over 14 months in Baltimore, Maryland and aims to advance the CDC's understanding of coronavirus disease 2019 (COVID-19) transmission and severity among children. Major subcontractors include Abt Associates Inc. to develop and administer a study database and provide reports and consultation, Malvern Medical Developments Limited to supply oropharyngeal specimen collection swabs, and Sino Biological US Inc. to provide spike and hemagglutinin proteins. No set aside designation was specified.

Generated 12/29/23, 2:47 PM